Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wouter Hoefsloot

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Open Forum Infectious Diseases|October 21, 2022
Amikacin Liposomal Inhalation Suspension in the Treatment of <i>Mycobacterium abscessus</i> Lung Infection: A French Observational ExperienceRaphael Chiron, Wouter Hoefsloot, Jakko Van Ingen, et al.
The European Respiratory Journal|July 13, 2019
Same meat, different gravy: ignore the new names of mycobacteriaEnrico Tortoli, Barbara A Brown-Elliott, James D Chalmers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2020
Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel SurveyJakko van Ingen, Stefano Aliberti, Claire Andrejak, et al.
Journal of Clinical Pharmacology|September 23, 2021
Prediction of Moxifloxacin Concentrations in Tuberculosis Patient Populations by Physiologically Based Pharmacokinetic ModelingCarlijn H C Litjens, Laurens F M Verscheijden, Celine Bolwerk, et al.
The Journal of Infectious Diseases|February 1, 2021
Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19Nico A F Janssen, Inge Grondman, Aline H de Nooijer, et al.
The European Respiratory Journal|April 20, 2013
The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative studyWouter Hoefsloot, Jakko van Ingen, Claire Andrejak, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 7, 2019
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility studyOnno Akkerman, Alena Aleksa, Jan-Willem Alffenaar, et al.
The Lancet. Respiratory Medicine|June 20, 2021
Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trialJurjan Aman, Erik Duijvelaar, Liza Botros, et al.
The European Respiratory Journal|October 12, 2019
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global reportSergey Borisov, Edvardas Danila, Andrei Maryandyshev, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Open Forum Infectious Diseases|October 21, 2022
Amikacin Liposomal Inhalation Suspension in the Treatment of <i>Mycobacterium abscessus</i> Lung Infection: A French Observational ExperienceRaphael Chiron, Wouter Hoefsloot, Jakko Van Ingen, et al.
The European Respiratory Journal|July 13, 2019
Same meat, different gravy: ignore the new names of mycobacteriaEnrico Tortoli, Barbara A Brown-Elliott, James D Chalmers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2020
Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel SurveyJakko van Ingen, Stefano Aliberti, Claire Andrejak, et al.
Journal of Clinical Pharmacology|September 23, 2021
Prediction of Moxifloxacin Concentrations in Tuberculosis Patient Populations by Physiologically Based Pharmacokinetic ModelingCarlijn H C Litjens, Laurens F M Verscheijden, Celine Bolwerk, et al.
The Journal of Infectious Diseases|February 1, 2021
Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19Nico A F Janssen, Inge Grondman, Aline H de Nooijer, et al.
The European Respiratory Journal|April 20, 2013
The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative studyWouter Hoefsloot, Jakko van Ingen, Claire Andrejak, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 7, 2019
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility studyOnno Akkerman, Alena Aleksa, Jan-Willem Alffenaar, et al.
The Lancet. Respiratory Medicine|June 20, 2021
Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trialJurjan Aman, Erik Duijvelaar, Liza Botros, et al.
The European Respiratory Journal|October 12, 2019
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global reportSergey Borisov, Edvardas Danila, Andrei Maryandyshev, et al.
Pageof 8